Targeting cancer at the nanoscale

Scientists from the Department of Nuclear Medicine and Tracer Kinetics at Osaka University developed a novel system for targeted cancer radiation therapy that uses gold nanoparticles labeled with astatine-211. Owing to the limited range and half-life of the radiation, along with the localization of the nanoparticles, healthy cells are considerably less likely to be harmed. This work may lead to effective cancer treatments without the side effects of current techniques. Continue reading at Physorg